Show simple item record

dc.contributor.authorBetancor-Fernández, Isabel
dc.identifier.citationBetancor-Fernández, Isabel. Gallblader carcinomas from risk factors to targeted therapy. AMU. 2018; 59-69es_ES
dc.description.abstractTo revise the epidemiology, pathogenesis, diagnosis, treatment and prognosis in gallbladder carcinomas. To revise the role of molecular pathology in this entity and its importance in therapeutic perspectives. Methods: A revision of all the articles published between 2006-2016 and indexed in PubMed containing the keywords “gallbladder”, “cancer”, “carcinoma”, “diagnosis”, “treatment”, “perspectives” and/or “targeted therapy ” was carried out. Results: The incidence of gallbladder carcinoma varies greatly depending on the geographical area [considered]. Its natural history is related to chronic inflammation and cholelithiasis is its main risk factor. The diagnosis is usually made at a late stage and, despite the treatment, it shows/has a poor prognosis. Changes in p53 and K-Ras are common. Modulation of inflammation is postulated as a therapeutic alternative. Conclusions: Gallbladder carcinoma is a neoplasm with an aggressive course. The improvement in its prognosis needs of the control of risk factors and early diagnosis supported by imaging tests. New surgical techniques and the description of new therapeutic targets also offer promising prospects.es_ES
dc.publisherArchivos de Medicina Universitariaes_ES
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 España*
dc.subjectGallbladder es_ES
dc.subjectTreatment es_ES
dc.subjectProspects es_ES
dc.titleGallblader carcinomas from risk factors to targeted therapyes_ES

Files in this item


This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial-SinDerivadas 3.0 España
Except where otherwise noted, this item's license is described as Atribución-NoComercial-SinDerivadas 3.0 España